CA50785-2B - 0x0000000000006BE4
Healthy Males & Females
Forward
* Stipend may pay up to reflected amount.
Start Date:
June 15, 2026 - 4:15pm
End Date:
June 23, 2026 - 10:45am
Study Details
Study Number: CA50785
Group Number: 2B
Study Requirement: Healthy Normal Male and Female
Stipend: up to $3,000.00
Study Criteria
Age: 19 - 55
BMI: 18 - 30
Weight Restriction: minimum weight 111 lbs
Study Information
Indication: This investigational medication is being developed for the treatment of multiple sclerosis (MS).
Route of Administration: Oral
Blood Draws: 16
Study Schedule
Schedule Type: Short stays with returns
Study Length: 3 Night Stay & 1 Return
Screening Dates:
| Event Day | Event Date |
|---|---|
| Tuesday | 6/2/2026 |
| Friday | 6/5/2026 |
| Tuesday | 6/9/2026 |
Doctor Exam Dates:
| Event Day | Event Date |
|---|---|
| Tuesday | 6/2/2026 |
| Friday | 6/5/2026 |
| Tuesday | 6/9/2026 |
Study Dates:
| Event Type | Start Day | Start Date | End Day | End Date | Phase | Site |
|---|---|---|---|---|---|---|
| Check-In | Monday | 6/15/2026 4:15:00 PM | Thursday | 6/18/2026 10:45:00 AM | 1 | Lincoln |
| Return | Tuesday | 6/23/2026 9:45:00 AM | Tuesday | 6/23/2026 10:45:00 AM | 1 | Lincoln |
